These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 796389)

  • 1. Partial purification of human leucocyte migration inhibitory factor (LIF) by immunosorption of supernatant protein contaminants detected by crossed immunoelectrophorsis.
    Bendtzen K
    J Immunol Methods; 1976; 13(3-4):321-31. PubMed ID: 796389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of a lymphoid cell line product with leukocyte inhibitory factor activity.
    Meshulam DH; Blair HE; Wong BL; Charm S; Minowada J; Rocklin RE
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):601-5. PubMed ID: 6952211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charge-reducing lymphokine activity in Concanavalin A-stimulated lymphocyte supernatants: preliminary biological and biochemical characterization.
    Kotzsch M; Grossmann H; Irmscher J; Wagner H; Müller M
    Biomed Biochim Acta; 1984; 43(1):57-65. PubMed ID: 6372798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).
    Rocklin RE
    J Immunol; 1975 Apr; 114(4):1161-5. PubMed ID: 1090666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of leucocyte migration inhibitory factor (LIF) in infectious mononucleosis. Spontaneous release and lack of response to concanavalin A.
    Palit J; Bendtzen K; Andersen V
    Clin Exp Immunol; 1978 Jan; 31(1):66-71. PubMed ID: 639351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Products of activated lymphocytes. I. The use of radiolabeling techniques in the characterization and partial purification of the migration inhibition factor of the guinea pig.
    Sorg C; Bloom BR
    J Exp Med; 1973 Jan; 137(1):148-70. PubMed ID: 4688317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the human lymphokine leukocyte migration inhibitory factor (LIF) by a sensitive radioenzymatic assay. Inhibitory effect of cGMP on the esterolytic activity of highly purified LIF.
    Bendtzen K
    J Clin Lab Immunol; 1979 Apr; 2(1):37-43. PubMed ID: 95804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further purification of neutrophil migration inhibition factor from T lymphocytes (NIF-T): evidence that NIF-T and leukocyte inhibitory factor (LIF) are immunologically distinct.
    Weisbart RH; Chan G; Spolter L; Golde DW
    Clin Immunol Immunopathol; 1984 Sep; 32(3):269-74. PubMed ID: 6380843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An indirect assay for canine leukocyte migration inhibitory factor (LIF): demonstration of its species specificity.
    Ansfield MJ; Shalaby MR; Kaltreider HB
    J Immunol Methods; 1980; 34(1):43-8. PubMed ID: 6448271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chicken buffy coat leucocytes (BCL) as indicator cells for human leucocytes migration inhibitory factor (LIF).
    Bellina L; Salerno A
    J Immunol Methods; 1981; 43(3):277-81. PubMed ID: 7019345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The production of heterologous antibodies to the human lymphakine: leukocyte migration inhibitory factor (LIF).
    Bendtzen K
    Cell Immunol; 1977 Mar; 29(2):382-93. PubMed ID: 324638
    [No Abstract]   [Full Text] [Related]  

  • 12. Laurell crossed immunoelectrophoresis and affinity chromatography for the purification of a parasite antigen.
    Hillyer GV; Cervoni M
    J Immunol Methods; 1978; 20():385-90. PubMed ID: 418120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte inhibitory factor (LIF): two distinct molecular species.
    Brown AP; Rocklin RE
    J Immunol; 1979 Mar; 122(3):1059-61. PubMed ID: 36430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures.
    Friedrich W; Lazary S; Geczy C; de Weck AL
    Int Arch Allergy Appl Immunol; 1975; 49(4):504-18. PubMed ID: 1099010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of lymphocyte migration by human lymphokines. III. Characterization of a lymphocyte migration inhibitory factor (LyMIF35K).
    McFadden RG; Cruikshank WW; Center DM
    Cell Immunol; 1984 Apr; 85(1):154-67. PubMed ID: 6370461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
    Sherris D; Stohl W; Mayer L
    J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative immunoelectrophoresis of proteins in human erythrocyte membranes. Analysis of protein bands obtained by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
    Bjerrum OJ; Bhakdi S; Bog-Hansen TC; Knüfermann H; Wallach DF
    Biochim Biophys Acta; 1975 Nov; 406(4):489-504. PubMed ID: 52375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Crossed immunoblotting': identification of proteins after crossed immunoelectrophoresis and electrotransfer to nitrocellulose membranes.
    Bütikofer P; Frenkel EJ; Ott P
    J Immunol Methods; 1985 Nov; 84(1-2):65-71. PubMed ID: 3905973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations on antithrombin III in normal plasma and serum.
    Sas G; Pepper DS; Cash JD
    Br J Haematol; 1975 Jul; 30(3):265-72. PubMed ID: 1201212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.